MAGNI, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 31.273
AS - Asia 19.083
EU - Europa 15.586
SA - Sud America 2.557
AF - Africa 386
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 26
Totale 68.954
Nazione #
US - Stati Uniti d'America 30.008
SG - Singapore 6.183
CN - Cina 4.105
VN - Vietnam 3.826
IT - Italia 3.469
DE - Germania 2.300
HK - Hong Kong 2.261
RU - Federazione Russa 1.962
BR - Brasile 1.917
SE - Svezia 1.834
IE - Irlanda 1.577
CA - Canada 1.028
UA - Ucraina 904
GB - Regno Unito 898
FR - Francia 679
IN - India 551
FI - Finlandia 416
AT - Austria 403
KR - Corea 350
BD - Bangladesh 276
AR - Argentina 231
NL - Olanda 227
TR - Turchia 224
ID - Indonesia 193
ES - Italia 187
IQ - Iraq 183
PL - Polonia 168
JP - Giappone 156
ZA - Sudafrica 141
MX - Messico 138
DK - Danimarca 132
PK - Pakistan 119
SA - Arabia Saudita 104
BE - Belgio 95
EC - Ecuador 91
PH - Filippine 85
VE - Venezuela 77
CO - Colombia 72
CH - Svizzera 63
UZ - Uzbekistan 58
MA - Marocco 56
CL - Cile 46
PY - Paraguay 46
LT - Lituania 45
IR - Iran 38
MY - Malesia 38
AU - Australia 35
CZ - Repubblica Ceca 32
EG - Egitto 31
RO - Romania 31
KE - Kenya 30
JO - Giordania 29
PE - Perù 29
AZ - Azerbaigian 28
TN - Tunisia 28
IL - Israele 27
AE - Emirati Arabi Uniti 26
BG - Bulgaria 26
KZ - Kazakistan 26
UY - Uruguay 26
NP - Nepal 25
ET - Etiopia 23
TH - Thailandia 23
GR - Grecia 22
EU - Europa 20
LB - Libano 20
BO - Bolivia 19
JM - Giamaica 19
DZ - Algeria 18
OM - Oman 18
PT - Portogallo 18
TW - Taiwan 18
DO - Repubblica Dominicana 15
NO - Norvegia 14
KG - Kirghizistan 13
PS - Palestinian Territory 13
HN - Honduras 12
PA - Panama 12
SY - Repubblica araba siriana 11
AL - Albania 10
CR - Costa Rica 10
LV - Lettonia 10
BY - Bielorussia 9
MT - Malta 9
HU - Ungheria 8
QA - Qatar 8
RS - Serbia 8
TT - Trinidad e Tobago 8
BH - Bahrain 7
CI - Costa d'Avorio 7
KW - Kuwait 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
MU - Mauritius 6
NG - Nigeria 6
SI - Slovenia 6
BN - Brunei Darussalam 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
Totale 68.852
Città #
Ann Arbor 4.349
Singapore 3.517
Ashburn 3.054
Hong Kong 2.199
San Jose 1.993
Woodbridge 1.851
Fairfield 1.648
Dublin 1.531
Chandler 1.520
Milan 1.280
Houston 1.275
Frankfurt am Main 1.203
Ho Chi Minh City 1.148
Wilmington 1.022
Hanoi 883
Jacksonville 878
New York 833
Dallas 760
Dearborn 747
Seattle 696
Santa Clara 694
Los Angeles 591
Beijing 572
Cambridge 549
Hefei 503
Toronto 499
Chicago 484
Princeton 458
The Dalles 406
Vienna 343
Shanghai 329
Seoul 327
Nanjing 302
Lauterbourg 255
São Paulo 234
Buffalo 216
Moscow 208
Munich 207
Council Bluffs 190
Helsinki 189
Altamura 181
Lawrence 175
Lachine 143
Montréal 142
Da Nang 137
Orem 137
Dong Ket 127
Nanchang 119
Guangzhou 115
London 114
Warsaw 112
Jakarta 108
Haiphong 105
Fremont 100
Tokyo 97
Kent 94
Brussels 85
Brooklyn 84
Biên Hòa 82
Denver 82
Hải Dương 81
Baghdad 79
Chennai 78
Montreal 78
San Diego 78
Andover 77
Shenyang 77
Nuremberg 76
Rome 75
Ottawa 74
Changsha 73
Ha Long 69
Boardman 67
Hebei 66
Atlanta 65
Johannesburg 65
Rio de Janeiro 63
Amsterdam 62
Tianjin 62
Quận Bình Thạnh 61
Phoenix 60
Salt Lake City 60
Stockholm 60
Zhengzhou 58
Poplar 55
Ninh Bình 54
Tashkent 53
Manchester 52
Boston 50
Jinan 49
Pune 48
Thái Nguyên 48
Can Tho 45
Florence 45
Lissone 45
Turku 45
Jiaxing 44
Paris 43
San Francisco 43
Dhaka 41
Totale 44.706
Nome #
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 594
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 581
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 567
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 542
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 532
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 505
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 472
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 470
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 465
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 461
Differential protein profiling of renal cell carcinoma urinary exosomes 460
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 456
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 450
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 447
Urinary exosomes and diabetic nephropathy: a proteomic approach 445
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 442
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 441
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 434
The putative role of MALDI-MSI in the study of Membranous Nephropathy 421
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 416
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 412
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 408
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 403
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 393
The proteomic landscape of renal tumors 392
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 390
Urinary proteomics for the study of genetic kidney diseases 390
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 389
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 387
MALDI imaging in Fabry nephropathy: a multicenter study 387
Mutual Information Optimization for Mass Spectra Data Alignment 372
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 371
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 366
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 365
Proteomics imaging and the kidney 365
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 364
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 363
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 363
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 360
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 358
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 357
Proteomics for the diagnosis of thyroid lesions: Preliminary report 354
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 354
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 351
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 351
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 350
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 348
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 347
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 347
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 345
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 344
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 344
The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis 342
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 341
Proteomics for the study of new biomarkers in Fabry disease: State of the art 340
Robust conclusions in mass spectrometry analysis 338
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 337
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 337
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 336
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 332
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 331
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 330
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 325
Expression of heat shock protein 27 in human renal cell carcinoma 323
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 323
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 321
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 319
Tumor size, stage and grade alterations of urinary peptidome in RCC 314
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 314
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 313
Proteome analysis in thyroid pathology 309
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 307
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 306
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes 305
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 304
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 304
Proteomic knowledge of human aquaporins 302
Differential expression of AQP1 in microdomain-enriched membranes of Renal Cell Carcinoma 302
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 301
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 300
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 299
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 298
Analysis of correlation structures in renal cell carcinoma patient data 295
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 294
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 291
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 288
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 287
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 283
A molecular imaging approach to individuate tumour infiltrating lymphocytes 283
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 281
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 279
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 279
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 276
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 276
AQP1 expression analysis in human diseases: Implications for proteomic characterization 274
Intraluminal proteome and peptidome of human urinary extracellular vesicles 273
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 272
Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma 271
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 271
HNE-Abeta adducts evaluated in vitro and in washed platelets by HPLC-ESI-MS 270
Totale 35.987
Categoria #
all - tutte 212.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021703 0 0 0 0 0 0 0 0 0 0 260 443
2021/20223.275 261 296 307 415 200 267 119 192 157 244 282 535
2022/20236.038 672 1.860 486 603 352 861 72 375 381 62 183 131
2023/20244.729 138 156 192 320 517 1.360 990 125 295 76 121 439
2024/202510.317 472 928 598 459 902 393 568 461 1.112 1.657 1.043 1.724
2025/202626.763 4.153 2.229 2.292 3.037 3.134 1.418 4.045 1.218 2.136 2.260 841 0
Totale 70.307